This study illustrates the need for a better understanding of RCC tumorigenesis in ACKD, as it has the potential to reveal pathogenic mechanisms of RCC development beyond mutations in VHL, PBRM1, and BAP1. This evidence concerns the gene PBRM1 and renal cell carcinoma.